These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 332352)
1. Curability of non-Hodgkin's lymphomas. McKelvey EM; Moon TE Cancer Treat Rep; 1977 Sep; 61(6):1185-90. PubMed ID: 332352 [TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
3. Results of combination chemotherapy of non-Hodgkin's lymphoma. Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932 [TBL] [Abstract][Full Text] [Related]
4. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy. Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397 [TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin's lymphoma in children. Pinkel D; Johnson W; Aur RJ Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
8. Nodular lymphoma. Prolongation of survival by complete remission. Diggs CH; Wiernik PH; Ostrow SS Cancer Clin Trials; 1981; 4(2):107-14. PubMed ID: 7249248 [TBL] [Abstract][Full Text] [Related]
9. Proceedings of the Conference on non-Hodgkin's lymphomas: summary of symposium. DeVita VT Cancer Treat Rep; 1977 Sep; 61(6):1223-7. PubMed ID: 332356 [No Abstract] [Full Text] [Related]
10. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission. Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255 [TBL] [Abstract][Full Text] [Related]
11. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)]. Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402 [TBL] [Abstract][Full Text] [Related]
12. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies. Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007 [TBL] [Abstract][Full Text] [Related]
15. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma. Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937 [TBL] [Abstract][Full Text] [Related]
16. [5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence]. Jost LM; Pichert G; Reichlin M; Müller E; Jacky E; Honegger HP; Gmür J; Stahel RA Schweiz Med Wochenschr; 1993 May; 123(18):932-40. PubMed ID: 8098878 [TBL] [Abstract][Full Text] [Related]
17. Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients. Zinzani PL; Tani M; Molinari AL; Stefoni V; Zuffa E; Alinari L; Gabriele A; Bonifazi F; Salvucci M; Tura S; Baccarani M Haematologica; 2002 Aug; 87(8):816-21. PubMed ID: 12161357 [TBL] [Abstract][Full Text] [Related]
18. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)]. Gorin NC; David R; Stachowiak J; Najman A; Duhamel G Nouv Presse Med; 1976 Nov; 5(38):2525-30. PubMed ID: 790316 [TBL] [Abstract][Full Text] [Related]